213 related articles for article (PubMed ID: 32576017)
1. Efficacy and safety of radiotherapy for primary liver cancer.
Chen W; Chiang CL; Dawson LA
Chin Clin Oncol; 2021 Feb; 10(1):9. PubMed ID: 32576017
[TBL] [Abstract][Full Text] [Related]
2. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.
Kuo YC; Chiu YM; Shih WP; Yu HW; Chen CW; Wong PF; Lin WC; Hwang JJ
Radiat Oncol; 2011 Jun; 6():76. PubMed ID: 21693003
[TBL] [Abstract][Full Text] [Related]
3. Conformal and stereotactic radiotherapy in hepatocellular carcinoma.
Scorsetti M; Bignardi M
Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272
[TBL] [Abstract][Full Text] [Related]
4. Role of External Beam Radiotherapy in Hepatocellular Carcinoma.
Chen CP
Clin Liver Dis; 2020 Nov; 24(4):701-717. PubMed ID: 33012454
[TBL] [Abstract][Full Text] [Related]
5. Technical advances in external radiotherapy for hepatocellular carcinoma.
Park SH; Kim JC; Kang MK
World J Gastroenterol; 2016 Aug; 22(32):7311-21. PubMed ID: 27621577
[TBL] [Abstract][Full Text] [Related]
6. Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study.
Tanyi JA; Summers PA; McCracken CL; Chen Y; Ku LC; Fuss M
Radiat Oncol; 2009 Jul; 4():22. PubMed ID: 19591687
[TBL] [Abstract][Full Text] [Related]
7. Dose fall-off patterns with volumetric modulated arc therapy and three-dimensional conformal radiotherapy including the "organ at risk" effect. Experience of linear accelerator-based frameless radiosurgery from a single institution.
Munshi A; Sarkar B; Roy S; Ganesh T; Mohanti BK
Cancer Radiother; 2019 Apr; 23(2):138-146. PubMed ID: 30797691
[TBL] [Abstract][Full Text] [Related]
8. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic tumors and radiotherapy].
Rio E; Mornex F; Peiffert D; Huertas A
Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
[TBL] [Abstract][Full Text] [Related]
11. A dosimetric comparison between volumetric-modulated arc therapy and dynamic conformal arc therapy in SBRT.
Stathakis S; Narayanasamy G; Licon AL; Myers P; Li Y; Crownover R; Papanikolaou N
J BUON; 2019; 24(2):838-843. PubMed ID: 31128044
[TBL] [Abstract][Full Text] [Related]
12. Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma.
Zhang L; Xi M; Deng XW; Li QQ; Huang XY; Liu MZ
J Radiat Res; 2012 Sep; 53(5):769-76. PubMed ID: 22843361
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer planning: Complex conformal vs modulated therapies.
Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
[TBL] [Abstract][Full Text] [Related]
14. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy.
Matsuo Y; Yoshida K; Nishimura H; Ejima Y; Miyawaki D; Uezono H; Ishihara T; Mayahara H; Fukumoto T; Ku Y; Yamaguchi M; Sugimoto K; Sasaki R
J Radiat Res; 2016 Sep; 57(5):512-523. PubMed ID: 27053259
[TBL] [Abstract][Full Text] [Related]
16. The Feasibility and Efficiency of Volumetric Modulated Arc Therapy-Based Breath Control Stereotactic Body Radiotherapy for Liver Tumors.
Qiu JJ; Ge W; Zhang L; Yao Y; Zheng X
Technol Cancer Res Treat; 2016 Oct; 15(5):674-82. PubMed ID: 26206766
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
[TBL] [Abstract][Full Text] [Related]
18. High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.
Hou JZ; Zeng ZC; Wang BL; Yang P; Zhang JY; Mo HF
Jpn J Clin Oncol; 2016 Apr; 46(4):357-62. PubMed ID: 26802166
[TBL] [Abstract][Full Text] [Related]
19. A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma.
Wu ZF; Zhang JY; Shen XY; Zhou LY; Gao YB; Hu Y; Zeng ZC
Med Phys; 2016 Jul; 43(7):4349. PubMed ID: 27370150
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
